Dr. Rowena Ridout is a physician in the UHN/MSH Osteoporosis Programme and is an Assistant Professor of Medicine in the Division of Endocrinology & Metabolism at the University of Toronto. She has been involved in clinical research in osteoporosis including the attainment and maintenance of peak bone mass, the treatment of steroid-induced osteoporosis in children and interventions in the fracture clinic.
Dr. Ridout is currently the Chair of Osteoporosis Canada’s Scientific Advisory Council (SAC) and has served on a number of committees, including 6 years as the medical advisor to COPN. She is also a member of the 2023 Clinical Practice Guideline Steering Committee. Dr. Ridout is actively involved in medical education at both the undergraduate and postgraduate levels.